17143-Lung Cancer-NSCLC-1240

Lung Cancer

A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) (SPI-POZ-202)

  • Details

ClinicalTrials.gov ID: NCT03318939
Diagnosis Type: NSCLC
USOR Number: 17143

  • Address

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.